Pharma

Incyte Partners with Genesis to Develop and Commercialize Novel Small Molecules Using Genesis’ GEMS AI Platform

Incyte Partners with Genesis to Develop and Commercialize Novel Small Molecules Using Genesis’ GEMS AI Platform

Shots: Incyte has partnered with Genesis to advance research, discovery, & dev...

Harbour BioMed Enters into a Collaboration with Insilico Medicine to Advance AI-Driven Antibody Discovery and Development

Harbour BioMed Enters into a Collaboration with Insilico Medicine to Advance AI-Driven Antibody Discovery and Development

Shots: Harbour BioMed has entered into a strategic collaboration with Insilico Med...

CSPC Pharmaceutical Collaborates with Radiance Biopharma to Develop and Commercialize RB-164 (SYS6005) as an Anti-Cancer Therapy

CSPC Pharmaceutical Collaborates with Radiance Biopharma to Develop and Commercialize RB-164 (SYS6005) as an Anti-Cancer Therapy

Shots: CSPC has granted Radiance exclusive rights to develop & market RB-164 i...

Epitopea Partners with Merck to Discover Cryptigen Tumor-Specific Antigens Using Epitopea’s CryptoMap platform

Epitopea Partners with Merck to Discover Cryptigen Tumor-Specific Antigens Using Epitopea’s CryptoMap platform

Shots: Epitopea & Merck have entered into license & research collaboration...

Biogen Collaborates with Stoke Therapeutics to Develop and Commercialize Zorevunersen for Dravet Syndrome

Biogen Collaborates with Stoke Therapeutics to Develop and Commercialize Zorevunersen for Dravet Syndrome

Shots: Biogen & Stoke have partnered to develop & market zorevunersen for...

IDEAYA Enters Into an Additional Clinical Study Collaboration and Supply Agreement with Gilead Sciences

IDEAYA Enters Into an Additional Clinical Study Collaboration and Supply Agreement with Gilead Sciences

Shots: IDEAYA has entered into an additional clinical study...

Image